WATCH LIVE: Kevin Warsh testifies in Senate Banking confirmation hearing for Fed chair

The market is likely underpricing the institutional damage from a chair transition that is not cleanly sequenced. The real second-order risk is not the headline appointment itself, but a prolonged period where the chair, board, and White House are in visible conflict; that tends to push term premia higher even if front-end cuts eventually happen. In practice, that means the curve can steepen for reasons that are more about governance premium than pure macro data.

Warsh’s inflation-first framing is a warning for duration-heavy assets: if policy credibility gets interpreted as more hawkish or more politicized, breakevens can stay sticky while real yields rise, which is toxic for long-duration equities and especially rate-sensitive factor exposures. The market may also be missing the asymmetry that a messy confirmation could delay any true policy pivot by months, not weeks, because the Senate process and litigation risk create a veto point that keeps uncertainty elevated through summer.

A second-order beneficiary could be banks and select value sectors that gain from a higher-for-longer curve, but the better expression is relative: long financials vs. rate-sensitive growth, not an outright macro beta bet. On the other side, housing, homebuilders, REITs, and unprofitable tech remain the most vulnerable if the 10-year backs up 20–40 bps on governance risk alone. The contrarian view is that political theater may be louder than policy outcome; if inflation data softens and the nomination stalls, the Fed could stay effectively unchanged, which would cap the upside in yields and make aggressive hawkish positioning vulnerable to a quick reversal.